[1]王秋莉,刘应科,杨 晔,等.宣肺运脾方辅助西药治疗儿童哮喘并发反复呼吸道感染临床研究[J].陕西中医,2024,(10):1357-1360.[doi:DOI:10.3969/j.issn.1000-7369.2024.10.013]
　WANG Qiuli,LIU Yingke,YANG Ye,et al.Clinical study of Xuanfei Yunpi decoction supplemented with western medicine on asthma with recurrent respiratory tract infection in children[J].,2024,(10):1357-1360.[doi:DOI:10.3969/j.issn.1000-7369.2024.10.013]
点击复制

宣肺运脾方辅助西药治疗儿童哮喘并发反复呼吸道感染临床研究
分享到：

《陕西中医》[ISSN:1000-7369/CN:61-1281/TN]

卷:
期数:
2024年10期
页码:
1357-1360
栏目:
临床研究
出版日期:
2024-10-05

文章信息/Info

Title:
Clinical study of Xuanfei Yunpi decoction supplemented with western medicine on asthma with recurrent respiratory tract infection in children
作者:
王秋莉1; 刘应科1; 杨 晔1; 任昕昕1; 余惠平2
(1.北京市和平里医院儿科,北京 100013; 2.北京中医药大学东直门医院儿科,北京 100700)
Author(s):
WANG Qiuli; LIU Yingke; YANG Ye; REN Xinxin; YU Huiping
(Department of Pediatrics,Beijing Hepingli Hospital,Beijing 100013,China)
关键词:
哮喘;  宣肺运脾方;  舒利迭;  反复呼吸道感染;  儿童;  炎症因子;  免疫功能
Keywords:
Asthma;  Xuanfei Yunpi decoction;  Seretide;  Recurrent upper respiratory tract infection;  Children;  Inflammatory factors;  Immune function
分类号:
R 725.6
DOI:
DOI:10.3969/j.issn.1000-7369.2024.10.013
文献标志码:
A
摘要:
目的:探究宣肺运脾方辅助西药治疗哮喘并反复呼吸道感染儿童的临床价值。方法:将110例哮喘并发反复呼吸道感染患儿按抽签法分为西医组55例,使用西药治疗; 中西医结合组55例,使用宣肺运脾方加西药治疗。比较两组疗效指标、炎症因子、免疫功能及药物不良反应发生情况。结果:两组疗效指标、炎症因子、免疫功能比较差异均有统计学意义(P<0.05),中西医结合组治疗总有效率更高,呼吸道感染及哮喘发作次数、发热及咳嗽持续时间均更少(P<0.05),干扰素γ(IFN-γ)、辅助性T细胞CD3+、CD4+、CD4+/CD8+更高(P<0.05),白细胞介素13(IL-13)、基质金属蛋白酶9(MMP-9)、CD8+更低(P<0.05); 两组药物不良反应发生情况差异无统计学意义(P>0.05)。结论:西药联合宣肺运脾方治疗哮喘并反复呼吸道感染儿童可提高疗效,抑制炎症反应,改善免疫功能。
Abstract:
Objective:To explore the clinical value of Xuanfei Yunpi decoction supplemented with western medicine in the treatment of children with asthma complicated with recurrent respiratory tract infection.Methods:A total of 110 children with asthma and recurrent respiratory tract infection were divided into western medicine group(55 cases,with western medicine),and integrated Chinese and western medicine group(55 cases,Xuanfei Yunpi decoction + Western medicine)by drawing lots.The efficacy indicators,inflammatory factors,immune function and occurrence of adverse drug reactions were compared between groups.Results:There were statistical differences in the efficacy indicators,inflammatory factors and immune function between the two groups(P<0.05).The total effective rate of treatment in integrated Chinese and Western medicine group was higher,and the number of respiratory tract infections and the number of asthma attacks,duration of fever and duration of cough were less or shorter(P<0.05),and the levels of IFN-γ and helper T cell CD3+,CD4+ and CD4+/CD8+ were higher while the levels of interleukin 13(IL-13),matrix metalloproteinase 9(MMP-9)and CD8+ were lower(P<0.05).There was no statistical significance in the incidence of adverse drug reactions between the two groups(P>0.05).Conclusion:Western medicine plus Xuanfei Yunpi decoction on the basis of seretide can enhance the efficacy,inhibit the inflammatory response and improve the immune function in treating children with asthma complicated with recurrent respiratory tract infection.

参考文献/References:

[1] 毕潇文,李静.支气管哮喘合并肺炎支原体感染患儿血清白介素-6、25羟基维生素D、肿瘤坏死因子水平变化临床研究[J].陕西医学杂志,2022,51(1):63-66.
[2] 陆振瑜,庄承.益气补肾止喘汤联合布地奈德治疗小儿哮喘疗效研究[J].陕西中医,2022,43(6):728-731.
[3] BRITTAN M S,MOSS A,WATSON J D,et al.Association between early childhood lower respiratory tract infections and subsequent asthma[J].J Asthma,2022,59(11):2143-2153.
[4] 黄舒然,姚宏凤,丁海拔,等.参苓白术散联合沙美特罗氟替卡松治疗支气管哮喘慢性持续期疗效及对患者机体氧化-抗氧化平衡的影响[J].陕西中医,2023,44(6):730-733.
[5] 梁嫄,潘光霞,司秀影,等.从“调和营卫,改善免疫”论儿童哮喘缓解期的治疗[J].辽宁中医杂志,2022,49(8):55-58.
[6] 中华中医药学会肺系病分会.支气管哮喘中医诊疗专家共识(2012)[J].中医杂志,2013,54(7):627-629.
[7] 王力宁,汪受传,韩新民,等.小儿反复呼吸道感染中医诊疗指南[J].中医儿科杂志,2008,4(6):3-4.
[8] 中华儿科杂志编辑委员会,中华医学会儿科学分会呼吸学组,中国医师协会儿科医师分会儿童呼吸专业委员会.儿童支气管哮喘规范化诊治建议(2020年版)[J].中华儿科杂志,2020,58(9):708-717.
[9] 中华医学会儿科学分会呼吸学组,《中华儿科杂志》编辑委员会.反复呼吸道感染的临床概念和处理原则[J].中华儿科杂志,2008,46(2):108-110.
[10] 中华中医药学会.中医儿科常见病诊疗指南[M].北京:中国中医药出版社,2012:1-82.
[11] 黄莉萍,卢姝亚,彭东红.沙美特罗/丙酸氟替卡松与丙酸氟替卡松在儿童哮喘升阶梯治疗中有效性及安全性的系统评价和Meta分析[J].中国循证儿科杂志,2023,18(5):355-361.
[12] ALIZADEH B A,AZIZ M I,MAITLAND D Z,et al.Recent advances in the treatment of childhood asthma:A clinical pharmacology perspective[J].Expert Rev Clin Pharmacol,2022,15(10):1165-1176.
[13] 尚燕春,孙丽娜,马静,等.沙美特罗替卡松吸入粉雾剂的临床应用及仿制药研发现状[J].中国临床药理学杂志,2020,36(22):3818-3822.
[14] CHRISTOU E A,GIARDINO G,STEFANAKI E,et al.Asthma:An undermined state of immunodeficiency[J].Int Rev Immunol,2019,38(2):70-78.
[15] 孙境孺,李竹英.NF-κB信号通路在肺部疾病中的作用研究进展及中医药干预现状[J].陕西中医,2022,43(7):972-974,978.
[16] CHAUHAN B F,CHARTRAND C,NI CHROININ M,et al.Addition of long-acting beta2-agonists to inhaled corticosteroids for chronic asthma in children[J].Cochrane Database Syst Rev,2015(11):7949.
[17] THOMAS D,MCDONALD V M,PAVORD I D,et al.Asthma remission:What is it and how can it be achieved?[J].Eur Respir J,2022,60(5):2102583.
[18] 中国中西医结合学会呼吸病专业委员会.支气管哮喘中西医结合诊疗中国专家共识[J].中国中西医结合杂志,2023,43(1):12-20.
[19] 莫珊,蔡靖宜,吴声振,等.健脾补肺膏联合天灸对脾肺气虚型小儿反复呼吸道感染患者的临床疗效[J].中成药,2023,45(6):2102-2104.
[20] 杨婧兴,蔡超,赵妍,等.黄芩苷在呼吸道黏膜慢性炎症性疾病中的抗炎作用及机制研究进展[J].首都医科大学学报,2022,43(6):919-923.
[21] 颜培正,王彬,刘安峰,等.黄芪通过mTOR通路调控细胞自噬减轻哮喘寒饮蕴肺证大鼠气道炎症的机制研究[J].时珍国医国药,2023,34(3):562-565.
[22] 陈淇,李湘銮,曾晓房,等.砂仁多糖提取及其生物活性研究进展[J].食品安全质量检测学报,2023,14(4):232-238.
[23] 夏召弟,马若昕,王凤云,等.党参免疫调节活性及其机制的研究进展[J].中草药,2023,54(13):4334-4345.
[24] 汪景,位佳琳,何蕊,等.网络药理学方法预测附子-熟地黄配伍治疗COPD作用机制以及初步验证研究[J].中国免疫学杂志,2022,38(4):419-426.
[25] 刘红淼,李艳玲,黄志云.桑白皮药理作用研究进展[J].中国实验方剂学杂志,2019,25(20):229-234.

相似文献/References:

[1]李艳,曾晓翠.加味射干麻黄汤对小儿咳嗽变异性哮喘的疗效观察[J].陕西中医,2016,(10):1311.
[2]伍 磊.紫苏子汤对哮喘小鼠TNFα、白细胞介素8、白介素1β表达的影响*[J].陕西中医,2019,(2):152.
　WU Lei..Effects of Zisuzi decoction on expression of TNF α，interleukin 8 and interleukin 1 β in asthmatic mice[J].,2019,(10):152.
[3]王玉梅,袁向东,李四保.止咳平喘糖浆联合异丙托溴铵治疗哮喘疗效及对患儿肺功能和内环境的影响*[J].陕西中医,2019,(4):428.
　WANG Yumei,YUAN Xiangdong,LI Sibao..Curative effect of cough relieving asthma syrup combined with ipratropium bromide on children with asthma and its influence on pulmonary function and internal environment[J].,2019,(10):428.
[4]汪 伟,赵跃萍,张亚明.补中益气方联合针灸治疗哮喘疗效及对患儿大气道功能相关指标的影响*[J].陕西中医,2020,(11):1611.[doi:DOI:10.3969/j.issn.1000-7369.2020.11.025]
　WANG Wei,ZHAO Yueping,ZHANG Yaming..Effect of Buzhong Yiqi recipe combined with acupuncture and moxibustion on therapeutic effect and changes of large airway function indexes in children with asthma[J].,2020,(10):1611.[doi:DOI:10.3969/j.issn.1000-7369.2020.11.025]
[5]陈训春,李名兰,潘碧云,等.白芥子散对哮喘大鼠免疫稳态重建及RhoA基因表达的影响[J].陕西中医,2021,(7):836.[doi:DOI:10.3969/j.issn.1000-7369.2020.07.005]
　CHEN Xunchun,LI Minglan,PAN Biyun,et al.Immune steady-state reconstruction of sputum drug Baijiezi powder on asthmatic rats and its effect on RhoA gene expression[J].,2021,(10):836.[doi:DOI:10.3969/j.issn.1000-7369.2020.07.005]
[6]刘 健,王佳丽,曹慧丹,等.补肺颗粒对哮喘小鼠气道重塑的影响及机制研究[J].陕西中医,2022,(5):559.[doi:DOI:10.3969/j.issn.1000-7369.2022.05.004]
　LIU Jian,WANG Jiali,CAO Huidan,et al.Mechanism of Bufei granule inhibiting airway remodeling in asthmatic mice[J].,2022,(10):559.[doi:DOI:10.3969/j.issn.1000-7369.2022.05.004]
[7]陆振瑜,庄 承.益气补肾止喘汤联合布地奈德治疗小儿哮喘疗效研究[J].陕西中医,2022,(6):728.[doi:DOI:10.3969/j.issn.1000-7369.2022.06.012]
　LU Zhenyu,ZHUANG Cheng.Effect research on Yiqi Bushen Zhichuan decoction combined with budesonide treatment of children with asthma[J].,2022,(10):728.[doi:DOI:10.3969/j.issn.1000-7369.2022.06.012]
[8]李 星,田春燕,王丽洁,等.李竹英教授治疗哮喘经验[J].陕西中医,2022,(7):936.[doi:DOI:10.3969/j.issn.1000-7369.2022.07.030]
　LI Xing,TIAN Chunyan,WANG Lijie,et al.Professor LI Zhuying's experience in treating asthma[J].,2022,(10):936.[doi:DOI:10.3969/j.issn.1000-7369.2022.07.030]
[9]孙境孺,李竹英.NF-κB信号通路在肺部疾病中的作用研究进展及中医药干预现状[J].陕西中医,2022,(7):972.[doi:DOI:10.3969/j.issn.1000-7369.2022.07.039]
　SUN Jingru,LI Zhuying.Research progress of role of NF-κB signaling pathway in lung diseases and the current situation of traditional Chinese medicine intervention[J].,2022,(10):972.[doi:DOI:10.3969/j.issn.1000-7369.2022.07.039]
[10]梁 嫄,于海洋,司秀影,等.中药调控Notch通路治疗哮喘作用机制研究进展[J].陕西中医,2022,(7):975.[doi:DOI:10.3969/j.issn.1000-7369.2022.07.040]
　LIANG Yuan,YU Haiyang,SI Xiuying,et al.Research progress on mechanism of traditional Chinese medicine regulating Notch pathway in treating asthma[J].,2022,(10):975.[doi:DOI:10.3969/j.issn.1000-7369.2022.07.040]

备注/Memo

备注/Memo:
基金项目:中华中医药学会求实项目(2021-QNQS-02)
更新日期/Last Update: 2024-10-08